|
humans |
17 |
|
male |
17 |
|
adult |
15 |
|
middle aged |
15 |
|
bronchiectasis |
12 |
|
female |
11 |
|
aged |
10 |
|
cigarette smoking |
10 |
|
medical sciences |
10 |
|
nitric oxide |
10 |
|
apoptosis |
9 |
|
obstructive sleep apnea |
9 |
|
anti-inflammatory agents - pharmacology |
8 |
|
catalase |
8 |
|
cells, cultured |
8 |
|
cigarette smoke |
8 |
|
lung cancer |
8 |
|
obesity |
8 |
|
respiratory diseases |
8 |
|
superoxide dismutase |
8 |
|
airway epithelial cells |
7 |
|
c-reactive protein |
7 |
|
drug modulation |
7 |
|
endothelial function |
7 |
|
epithelial cells |
7 |
|
forced expiratory volume - physiology |
7 |
|
interleukin-6 |
7 |
|
intermittent hypoxia |
7 |
|
pseudomonas aeruginosa |
7 |
|
smoking |
7 |
|
vital capacity |
7 |
|
5-fluorouracil |
6 |
|
aged, 80 and over |
6 |
|
asian continental ancestry group |
6 |
|
atherosclerosis |
6 |
|
biological markers - analysis |
6 |
|
body mass index |
6 |
|
breast cancer |
6 |
|
bronchial epithelial cells |
6 |
|
bronchiectasis - metabolism |
6 |
|
c-reactive protein - analysis |
6 |
|
chronic obstructive pulmonary disease |
6 |
|
cilia |
6 |
|
ciliary central microtubular orientation |
6 |
|
covid-19 |
6 |
|
erythrocytes - enzymology |
6 |
|
glutathione peroxidase |
6 |
|
interleukin-6 - biosynthesis |
6 |
|
intra-abdominal fat |
6 |
|
proanthocyanidins |
6 |
|
regression analysis |
6 |
|
rna, messenger - analysis |
6 |
|
sars-cov-2 |
6 |
|
sensitivity and specificity |
6 |
|
sleep apnea, obstructive - metabolism |
6 |
|
transmission electronic microscopy |
6 |
|
uncaria rhynchophylla |
6 |
|
visceral fat |
6 |
|
waist circumference |
6 |
|
administration, inhalation |
5 |
|
advanced glycation end-products |
5 |
|
androstadienes - administration & dosage |
5 |
|
asthma |
5 |
|
biomarkers |
5 |
|
bronchiectasis - drug therapy |
5 |
|
cell apoptosis (细胞凋亡) |
5 |
|
chronic obstructive (慢性阻塞性) |
5 |
|
dose-response relationship, drug |
5 |
|
endothelial progenitor cells |
5 |
|
enzyme-linked immunosorbent assay |
5 |
|
inflammatory effect (炎症反应) |
5 |
|
inhaled corticosteroid therapy |
5 |
|
interleukin-8 |
5 |
|
obstructive pulmonary disease (阻塞性肺疾病) |
5 |
|
oxidative stress |
5 |
|
reverse transcriptase polymerase chain reaction |
5 |
|
sleep apnea syndrome (睡眠呼吸暂停综合征) |
5 |
|
up-regulation |
5 |
|
airspace enlargement |
4 |
|
animal experiment |
4 |
|
animals |
4 |
|
anti-inflammatory agents, non-steroidal - pharmacology |
4 |
|
antineoplastic agents - therapeutic use |
4 |
|
antioxidants - analysis - metabolism |
4 |
|
antioxidants - pharmacology |
4 |
|
blotting, western |
4 |
|
brain natriuretic peptide |
4 |
|
bronchi - immunology |
4 |
|
bronchiectasis - blood - etiology |
4 |
|
bronchiectasis - immunology |
4 |
|
carcinoma, non-small-cell lung - drug therapy |
4 |
|
carcinoma, non-small-cell lung - enzymology - etiology - pathology |
4 |
|
case-control studies |
4 |
|
catalase - analysis - metabolism |
4 |
|
catechin - analogs and derivatives - pharmacology |
4 |
|
cell transformation, neoplastic - metabolism |
4 |
|
china |
4 |
|
chinese green tea (lung chen) |
4 |
|
contraction |
4 |
|
copd |
4 |
|
coriolus versicolor |
4 |
|
cyclooxygenase 2 inhibitors - pharmacology |
4 |
|
dexamethasone |
4 |
|
dexamethasone - pharmacology |
4 |
|
disease progression |
4 |
|
double-blind method |
4 |
|
endothelial nitric oxide synthase |
4 |
|
epithelial cells - drug effects - immunology |
4 |
|
glutathione peroxidase - analysis - metabolism |
4 |
|
goblet cell |
4 |
|
goblet cells - drug effects - pathology |
4 |
|
hypertension |
4 |
|
immunosuppressive agents - pharmacology |
4 |
|
induced pluripotent stem cell |
4 |
|
inflammation |
4 |
|
intercellular adhesion molecule-1 - analysis |
4 |
|
intercellular cell adhesion molecule |
4 |
|
lung injury - drug therapy |
4 |
|
lung neoplasms - drug therapy |
4 |
|
lung neoplasms - enzymology - etiology - pathology |
4 |
|
mesenchymal stem cell |
4 |
|
mitochondrial transfer |
4 |
|
neoplasm staging |
4 |
|
non-small cell lung cancer |
4 |
|
oxidative stress - drug effects |
4 |
|
oxidoreductases - analysis - metabolism |
4 |
|
palliative treatment |
4 |
|
pilot projects |
4 |
|
polysaccharide peptides (psp) |
4 |
|
proliferation |
4 |
|
proteoglycans - therapeutic use |
4 |
|
rats |
4 |
|
serum |
4 |
|
species specificity |
4 |
|
stem cell factor |
4 |
|
superoxide dismutase - analysis - metabolism |
4 |
|
transforming growth factor beta - metabolism |
4 |
|
transforming growth factor beta1 |
4 |
|
transforming growth factor-β1 |
4 |
|
troponin |
4 |
|
tumor necrosis factor-alpha - analysis - pharmacology |
4 |
|
tumor necrosis factor-α |
4 |
|
vasoconstriction - drug effects |
4 |
|
1-(5-isoquinolinesulfonyl)-2-methylpiperazine - analogs & derivatives - chemistry - pharmacology |
3 |
|
adenocarcinoma - ethnology - genetics |
3 |
|
adipocyte fatty acid–binding protein |
3 |
|
adiponectin |
3 |
|
adiponectin - blood |
3 |
|
adolescent |
3 |
|
airway inflammation |
3 |
|
alzheimer disease |
3 |
|
amides - chemistry - pharmacology |
3 |
|
amino acid substitution |
3 |
|
amino acids - pharmacology |
3 |
|
anoxia - metabolism - physiopathology |
3 |
|
antihypertensive agents - chemistry - pharmacology |
3 |
|
antioxidants |
3 |
|
aorta, thoracic - drug effects - enzymology - physiopathology |
3 |
|
arsenic trioxide |
3 |
|
asian continental ancestry group - genetics |
3 |
|
bacterial adherence |
3 |
|
bacterial adhesion - drug effects - physiology |
3 |
|
basement membrane |
3 |
|
basement membrane - drug effects - physiopathology - ultrastructure |
3 |
|
biological markers - blood |
3 |
|
biology |
3 |
|
blotting, northern |
3 |
|
bronchi - cytology - drug effects - metabolism |
3 |
|
bronchiectasis - physiopathology |
3 |
|
budesonide - pharmacology |
3 |
|
c-reactive protein - metabolism |
3 |
|
calcium sensitization |
3 |
|
carbohydrates - pharmacology |
3 |
|
carcinoma of lung |
3 |
|
catalase - genetics - metabolism |
3 |
|
collagen |
3 |
|
collagen type iv - drug effects - physiology - ultrastructure |
3 |
|
colony count, microbial |
3 |
|
continuous positive airway pressure |
3 |
|
coronary vessels - drug effects - metabolism - physiopathology |
3 |
|
cyclic adenosine monophosphate |
3 |
|
cyclic gmp - metabolism |
3 |
|
cystic fibrosis - physiopathology |
3 |
|
cytoskeleton |
3 |
|
dendrobium officinale |
3 |
|
dentate gyrus |
3 |
|
endocytosis |
3 |
|
endothelium, vascular - drug effects - enzymology - physiology |
3 |
|
endothelium, vascular - drug effects - metabolism - physiopathology |
3 |
|
epidermal growth factor receptor |
3 |
|
flavonoids |
3 |
|
gene frequency |
3 |
|
genetic predisposition to disease - ethnology |
3 |
|
genetic susceptibility |
3 |
|
genotype |
3 |
|
human bronchial epithelial cells |
3 |
|
hypertension - drug therapy - enzymology - physiopathology |
3 |
|
in situ hybridization |
3 |
|
ions - pharmacology |
3 |
|
isometric contraction - drug effects |
3 |
|
lectins - pharmacology |
3 |
|
lipopolysaccharide |
3 |
|
lung |
3 |
|
lung adenocarcinoma |
3 |
|
lung function |
3 |
|
lung neoplasms - enzymology - ethnology - genetics |
3 |
|
malondialdehyde (mda) |
3 |
|
microscopy, electron, scanning |
3 |
|
nitric oxide - metabolism |
3 |
|
oncology |
3 |
|
peptide |
3 |
|
polymerase chain reaction |
3 |
|
polymorphism, genetic |
3 |
|
polysaccharides |
3 |
|
pseudomonas aeruginosa - drug effects - physiology - ultrastructure |
3 |
|
pulmonary disease, chronic obstructive - blood - physiopathology |
3 |
|
pulmonary surfactant |
3 |
|
pyridines - chemistry - pharmacology |
3 |
|
rats, inbred shr |
3 |
|
rats, inbred wky |
3 |
|
reactive oxygen species |
3 |
|
rho-associated kinases - antagonists & inhibitors - biosynthesis |
3 |
|
rna probes |
3 |
|
rna, messenger - biosynthesis |
3 |
|
rna, messenger - drug effects - metabolism |
3 |
|
serotonin |
3 |
|
sirna delivery |
3 |
|
smoking - blood |
3 |
|
soluble guanylyl cyclase |
3 |
|
superoxide dismutase - blood - genetics - metabolism |
3 |
|
surfactant protein b |
3 |
|
thymidylate synthase |
3 |
|
tissue inhibitor of metalloproteinase |
3 |
|
xenograft |
3 |
|
(-)-epigallocatechin-3-gallate |
2 |
|
5-hydroxytryptamine (5-ht) |
2 |
|
acetylcysteine |
2 |
|
activity |
2 |
|
adipocyte |
2 |
|
adipogenesis |
2 |
|
adipose inflammation |
2 |
|
adipose tissue |
2 |
|
advanced oxidation protein products (aopp) |
2 |
|
aerosol |
2 |
|
age |
2 |
|
age factors |
2 |
|
airway epithelium |
2 |
|
airway hyperresponsiveness |
2 |
|
airway remodeling |
2 |
|
airway smooth muscle |
2 |
|
alleles |
2 |
|
alzheimer |
2 |
|
androstadienes - pharmacology |
2 |
|
animal modelanimal tissue |
2 |
|
antioxidant |
2 |
|
aortic endothelial cells |
2 |
|
asthma - blood - genetics |
2 |
|
asthma - enzymology - epidemiology - genetics |
2 |
|
asthma - genetics |
2 |
|
asthma - metabolism |
2 |
|
atherogenesis |
2 |
|
atopy |
2 |
|
autophagy |
2 |
|
bal |
2 |
|
base sequence |
2 |
|
beta-amyloid |
2 |
|
binding, competitive |
2 |
|
bronchoalveolar lavage |
2 |
|
calcium signaling |
2 |
|
cardiomyocytes |
2 |
|
cardiovascular disease |
2 |
|
catalase - blood |
2 |
|
catalase - genetics |
2 |
|
cell damage |
2 |
|
cell line |
2 |
|
child |
2 |
|
chinese population |
2 |
|
cholesterol |
2 |
|
chronic obstructive lung disease |
2 |
|
chronic obstructive pulmonary disease (copd) |
2 |
|
cigarette smoke (cs) |
2 |
|
cigarette smoke medium |
2 |
|
cisplatin |
2 |
|
controlled release |
2 |
|
cycloheximide - pharmacology |
2 |
|
cyclooxygenase |
2 |
|
cytokine-induced neutrophil chemoattractant-1 (cinc-1) |
2 |
|
dactinomycin - pharmacology |
2 |
|
disease association |
2 |
|
disease severity |
2 |
|
down-regulation |
2 |
|
drug delivery |
2 |
|
enzyme linked immunosorbent assay |
2 |
|
epigallocatechin gallate |
2 |
|
epithelial cell |
2 |
|
epithelial cells - drug effects - metabolism |
2 |
|
erlotinib |
2 |
|
erythrocyte |
2 |
|
etoposide |
2 |
|
fatty acid-binding protein |
2 |
|
fission |
2 |
|
fluticasone |
2 |
|
forced expiratory volume |
2 |
|
free radical scavengers |
2 |
|
gene expression |
2 |
|
gene expression regulation - drug effects |
2 |
|
genetic background |
2 |
|
genetic polymorphism |
2 |
|
genetic predisposition to disease |
2 |
|
genetic predisposition to disease - genetics |
2 |
|
glucocorticoids - pharmacology |
2 |
|
glutathione disulfide - blood |
2 |
|
glutathione disulfide, or oxidized gsh |
2 |
|
glutathione peroxidase - blood |
2 |
|
glutathione s-transferase |
2 |
|
glutathione transferase - blood - genetics |
2 |
|
glutathione transferase - physiology |
2 |
|
gpx |
2 |
|
gsh |
2 |
|
gssg |
2 |
|
guinea pigs |
2 |
|
haeme oxygenase-1 |
2 |
|
haemin |
2 |
|
half-life |
2 |
|
hb |
2 |
|
hemoglobin |
2 |
|
hong kong |
2 |
|
hong kong - epidemiology |
2 |
|
hong kong - ethnology |
2 |
|
hong kong chinese population |
2 |
|
houttuynia cordata |
2 |
|
hypoxia |
2 |
|
immunoglobulin enhancer binding protein |
2 |
|
inflammation - metabolism |
2 |
|
inositol trisphosphate receptor |
2 |
|
interleukin-1 - pharmacology |
2 |
|
interleukin-4 |
2 |
|
interleukin-4 - genetics |
2 |
|
interleukin-4 receptor |
2 |
|
interleukin-4 receptor alpha subunit - genetics |
2 |
|
interleukin-8 - secretion |
2 |
|
intermittent hypoxia (ih) |
2 |
|
logistic models |
2 |
|
lung - chemistry |
2 |
|
lung - cytology - metabolism |
2 |
|
lung - drug effects - metabolism |
2 |
|
lung - metabolism |
2 |
|
lymphotoxin-alpha - genetics |
2 |
|
lymphotoxin-α |
2 |
|
macrophages |
2 |
|
mechanism |
2 |
|
mechanistic pathway |
2 |
|
messenger ribonucleic acid |
2 |
|
metabolic syndrome |
2 |
|
microparticle |
2 |
|
mitochondria |
2 |
|
molecular sequence data |
2 |
|
monoamine oxidase |
2 |
|
monoamine oxidase (mao) |
2 |
|
monoamine oxidase-b |
2 |
|
mucus secretion |
2 |
|
neuroinflammation |
2 |
|
neutrophil infiltration |
2 |
|
nf-κb |
2 |
|
norepinephrine - pharmacology |
2 |
|
nucleic acid hybridization |
2 |
|
obstructive sleep apnea (osa) |
2 |
|
obstructive sleep apnoea |
2 |
|
oxidative stress - genetics |
2 |
|
oxidative stress - physiology |
2 |
|
oxidized glutathione |
2 |
|
pharmacy and pharmacology environmental studies |
2 |
|
phorbol 12,13-dibutyrate - pharmacology |
2 |
|
plasma |
2 |
|
polymorphism |
2 |
|
polymorphism, genetic - genetics |
2 |
|
polymorphism, restriction fragment length |
2 |
|
protein kinase c - drug effects - metabolism |
2 |
|
pseudomonas aeruginosa pyocyanin |
2 |
|
pulmonary disease, chronic obstructive - blood - genetics - physiopathology |
2 |
|
pulmonary disease, chronic obstructive - enzymology - ethnology - genetics |
2 |
|
pyocyanine - pharmacology |
2 |
|
radioligand assay |
2 |
|
rats, wistar |
2 |
|
receptors, muscarinic - analysis - genetics |
2 |
|
reduced glutathione |
2 |
|
reference values |
2 |
|
resistance |
2 |
|
retrospective studies |
2 |
|
risk factors |
2 |
|
rna, messenger - analysis - genetics |
2 |
|
rna, messenger - genetics |
2 |
|
rna, messenger - metabolism |
2 |
|
selegiline |
2 |
|
sex factors |
2 |
|
small cell lung cancer |
2 |
|
smoking - epidemiology - genetics |
2 |
|
smoking - genetics |
2 |
|
smoking - genetics - metabolism |
2 |
|
spectrophotometry |
2 |
|
superoxide anion |
2 |
|
superoxide dismutase - blood |
2 |
|
superoxide dismutase - genetics |
2 |
|
synergism |
2 |
|
time factors |
2 |
|
toxicology and environmental safety |
2 |
|
traditional chinese medicine |
2 |
|
transcription, genetic |
2 |
|
transforming growth factor beta - genetics |
2 |
|
transforming growth factor beta1 - blood - genetics |
2 |
|
tspo |
2 |
|
tumor necrosis factor-alpha - genetics |
2 |
|
(rat) |
1 |
|
(receptor expression) |
1 |
|
1-(5-isoquinolinesulfonyl)-2-methylpiperazine - pharmacology |
1 |
|
1-methyl-3-isobutylxanthine - pharmacology |
1 |
|
3',5'-cyclic-amp phosphodiesterases - metabolism |
1 |
|
a549 cells |
1 |
|
acetylcholine - metabolism |
1 |
|
acetylcholine - pharmacology |
1 |
|
adamantane - analogs & derivatives - pharmacology |
1 |
|
adenosine 3',5'-cyclic monophosphate |
1 |
|
adenylate cyclase - metabolism |
1 |
|
adenylyl cyclase |
1 |
|
administration, topical |
1 |
|
adrenergic beta-2 receptor agonists |
1 |
|
adrenergic beta-agonists - administration & dosage - pharmacology |
1 |
|
adrenergic beta-agonists - adverse effects - pharmacology |
1 |
|
adrenergic beta-agonists - metabolism |
1 |
|
adrenergic beta-agonists - pharmacology |
1 |
|
adrenergic beta-antagonists - metabolism - pharmacology |
1 |
|
adrenergic beta-antagonists - pharmacology |
1 |
|
aging - metabolism - physiology |
1 |
|
airway biology |
1 |
|
airway smooth muscle cells |
1 |
|
airway smooth muscle contraction |
1 |
|
airways |
1 |
|
albuterol - administration & dosage - analogs & derivatives - pharmacology |
1 |
|
albuterol - analogs & derivatives - pharmacology |
1 |
|
albuterol - pharmacology |
1 |
|
allergens - administration & dosage |
1 |
|
amino acid sequence |
1 |
|
amylin |
1 |
|
analysis of variance |
1 |
|
animals, genetically modified - genetics |
1 |
|
animals, newborn |
1 |
|
animals, newborn - physiology |
1 |
|
anoxia - metabolism |
1 |
|
anti-oxidant |
1 |
|
anticholinergics |
1 |
|
antigen challenge |
1 |
|
antigens - administration & dosage |
1 |
|
antioxidants - analysis |
1 |
|
antioxidants - metabolism |
1 |
|
arachidonic acid - antagonists & inhibitors - secretion |
1 |
|
asthma - epidemiology - genetics - physiopathology |
1 |
|
asthma - metabolism - physiopathology |
1 |
|
asthma - mortality |
1 |
|
atheroma |
1 |
|
atropine - pharmacology |
1 |
|
autoradiographic mapping |
1 |
|
autoradiography |
1 |
|
autoradiography - methods |
1 |
|
azepines - pharmacology |
1 |
|
benzamides - metabolism |
1 |
|
benzodiazepinones - metabolism |
1 |
|
beta-adrenergic receptor kinases |
1 |
|
binding sites |
1 |
|
binding sites - physiology |
1 |
|
binding, competitive - drug effects |
1 |
|
biotin |
1 |
|
biphenyl compounds - metabolism |
1 |
|
birth cohort |
1 |
|
blotting, northern - methods |
1 |
|
bone marrow-derived mscs (bm-mscs) |
1 |
|
bradykinin |
1 |
|
bradykinin - analogs & derivatives - antagonists & inhibitors - metabolism - pharmacology |
1 |
|
bradykinin b1 receptor |
1 |
|
bradykinin b2 receptor |
1 |
|
bradykinin receptors |
1 |
|
bronchi - cytology - enzymology |
1 |
|
bronchi - cytology - metabolism |
1 |
|
bronchi - drug effects - innervation - physiopathology |
1 |
|
bronchi - drug effects - physiology |
1 |
|
bronchial hyperreactivity - chemically induced - physiopathology |
1 |
|
bronchial provocation tests |
1 |
|
bronchial responsiveness |
1 |
|
bronchoalveolar lavage fluid - chemistry |
1 |
|
bronchoconstriction - drug effects |
1 |
|
bronchoconstriction - drug effects - genetics |
1 |
|
bronchodilator agents - chemistry - metabolism - therapeutic use |
1 |
|
bronchodilator agents - metabolism |
1 |
|
calcitonin |
1 |
|
calcitonin gene-related peptide - metabolism - physiology |
1 |
|
calcitonin gene-related peptide - pharmacology - physiology |
1 |
|
calcitonin gene-related peptide receptors |
1 |
|
calcitonin-gene-related peptide |
1 |
|
calla |
1 |
|
cancer chemoprevention |
1 |
|
capsaicin - pharmacology |
1 |
|
carbachol - pharmacology |
1 |
|
cardioprotection |
1 |
|
catalase - metabolism |
1 |
|
catechin |
1 |
|
cattle |
1 |
|
cd10 |
1 |
|
cell line, tumor |
1 |
|
cell nucleus - metabolism |
1 |
|
cell nucleus - metabolism - ultrastructure |
1 |
|
cerebral cortex - metabolism |
1 |
|
child development - physiology |
1 |
|
child, preschool |
1 |
|
chronic disease |
1 |
|
cimetidine - pharmacology |
1 |
|
cohort studies |
1 |
|
common acute lymphoblastic leukemia antigen |
1 |
|
computer simulation |
1 |
|
confidence intervals |
1 |
|
coronary artery disease - metabolism |
1 |
|
coronary vessels - metabolism |
1 |
|
corticosteroid |
1 |
|
creb |
1 |
|
cyclic amp |
1 |
|
cyclic amp - biosynthesis |
1 |
|
cyclic amp - metabolism |
1 |
|
cyclic amp - physiology |
1 |
|
cyclic amp-dependent protein kinases - genetics - metabolism |
1 |
|
cyclic amp-dependent protein kinases - metabolism |
1 |
|
cyclic amp-dependent protein kinases - physiology |
1 |
|
cyclooxygenase inhibitors - pharmacology |
1 |
|
cystic fibrosis |
1 |
|
cystic fibrosis - enzymology - genetics |
1 |
|
cytokines |
1 |
|
cytokines - pharmacology - physiology |
1 |
|
denervation |
1 |
|
des-arg10-kallidin |
1 |
|
desensitization |
1 |
|
dexamethasone - antagonists & inhibitors - pharmacology |
1 |
|
diamines - diagnostic use |
1 |
|
diamines - pharmacology |
1 |
|
dinoprostone - analysis |
1 |
|
dinoprostone - antagonists & inhibitors - secretion |
1 |
|
dinoprostone - biosynthesis - secretion |
1 |
|
dinoprostone - metabolism |
1 |
|
dinoprostone - pharmacology |
1 |
|
dipeptides - diagnostic use - metabolism |
1 |
|
dna - biosynthesis |
1 |
|
dna - metabolism |
1 |
|
dna primers |
1 |
|
down-regulation - drug effects |
1 |
|
downregulation |
1 |
|
drug interactions |
1 |
|
drug stability |
1 |
|
eccrine glands - chemistry |
1 |
|
electric stimulation |
1 |
|
electrophoresis |
1 |
|
embryo, mammalian |
1 |
|
endopeptidases - biosynthesis |
1 |
|
endothelin-1 - biosynthesis |
1 |
|
endothelium, vascular - drug effects - physiology |
1 |
|
enkephalinase |
1 |
|
environment |
1 |
|
enzyme activation |
1 |
|
enzyme inhibitors - pharmacology |
1 |
|
eosinophils |
1 |
|
epidermis |
1 |
|
epithelial cells - cytology - drug effects - metabolism |
1 |
|
epithelial cells - metabolism - pathology |
1 |
|
epithelium - enzymology |
1 |
|
epithelium - metabolism |
1 |
|
erythrocytes - metabolism |
1 |
|
ethanolamines - metabolism |
1 |
|
ethanolamines - pharmacology |
1 |
|
f ibroblasts |
1 |
|
fenoterol - adverse effects - pharmacology |
1 |
|
fenoterol - pharmacology |
1 |
|
ferrets |
1 |
|
fibroblasts - cytology - drug effects |
1 |
|
fibroblasts - drug effects - metabolism |
1 |
|
follow-up studies |
1 |
|
formoterol |
1 |
|
forskolin - pharmacology |
1 |
|
free radical scavengers - blood |
1 |
|
förster resonance energy transfer (fret) |
1 |
|
g protein |
1 |
|
g protein-coupled receptor |
1 |
|
g protein-coupled receptor kinase |
1 |
|
g proteins |
1 |
|
g-protein |
1 |
|
g-protein-coupled receptor kinase 3 |
1 |
|
g-protein-coupled receptor kinase 5 |
1 |
|
gene expression - drug effects |
1 |
|
gene expression regulation |
1 |
|
gene expression regulation - drug effects - genetics |
1 |
|
gene expression regulation, developmental |
1 |
|
gene transcription |
1 |
|
genetic polymorphisms |
1 |
|
genetic variation |
1 |
|
genetics |
1 |
|
glucocorticoid |
1 |
|
glucocorticoid receptor |
1 |
|
glucocorticoids |
1 |
|
glucocorticoids - genetics - metabolism |
1 |
|
glucocorticosteroid |
1 |
|
glucocorticosteroids |
1 |
|
glutathione |
1 |
|
glutathione - metabolism |
1 |
|
glutathione reductase |
1 |
|
green tea |
1 |
|
gtp-binding protein alpha subunits, gi-go - biosynthesis |
1 |
|
gtp-binding protein alpha subunits, gi-go - metabolism |
1 |
|
gtp-binding protein alpha subunits, gi-go - physiology |
1 |
|
gtp-binding protein alpha subunits, gs - biosynthesis |
1 |
|
gtp-binding protein alpha subunits, gs - physiology |
1 |
|
gtp-binding proteins - analysis |
1 |
|
gtp-binding proteins - metabolism |
1 |
|
guanosine 5'-o-(3-thiotriphosphate) - pharmacology |
1 |
|
guinea pig lung |
1 |
|
heart |
1 |
|
heart - drug effects |
1 |
|
heart transplantation |
1 |
|
heme oxygenase-1 |
1 |
|
histamine |
1 |
|
histamine - pharmacology |
1 |
|
histamine h1 antagonists - pharmacology |
1 |
|
histamine h1-receptor |
1 |
|
histamine h2 antagonists - pharmacology |
1 |
|
homologous regulation |
1 |
|
human lung |
1 |
|
hybridisation, in situ |
1 |
|
hydroxycorticosteroids - pharmacology |
1 |
|
hypersensitivity - metabolism - pathology |
1 |
|
hypertension, pulmonary - etiology - metabolism |
1 |
|
hypnotics and sedatives - metabolism |
1 |
|
hypobaric hypoxia |
1 |
|
hypothalamus |
1 |
|
imidazoles - metabolism - pharmacology |
1 |
|
immunohistochemistry |
1 |
|
in situ hybridisation |
1 |
|
in situ hybridization - methods |
1 |
|
indoles - diagnostic use - metabolism |
1 |
|
indoles - pharmacology |
1 |
|
indomethacin - pharmacology |
1 |
|
induced pluripotent-derived mesenchymal stem cells (ipsc-mscs) |
1 |
|
infant |
1 |
|
infant, newborn |
1 |
|
infusions, intravenous |
1 |
|
inhalation |
1 |
|
inhibitory concentration 50 |
1 |
|
injections, intravenous |
1 |
|
inositol phosphates - metabolism |
1 |
|
interleukin-1 - pharmacology - physiology |
1 |
|
interleukin-8 - genetics - metabolism |
1 |
|
iodine radioisotopes |
1 |
|
iodine radioisotopes - diagnostic use |
1 |
|
ipratropium - chemistry - metabolism - therapeutic use |
1 |
|
islet amyloid polypeptide |
1 |
|
isoproterenol - administration & dosage - pharmacology |
1 |
|
isoproterenol - metabolism - pharmacology |
1 |
|
isoproterenol - pharmacology |
1 |
|
isoquinolines - pharmacology |
1 |
|
keratinocytes - chemistry |
1 |
|
kinetics |
1 |
|
ligand binding |
1 |
|
ligand binding studies |
1 |
|
ligands |
1 |
|
luciferases - metabolism |
1 |
|
lung (human) |
1 |
|
lung - analysis |
1 |
|
lung - blood supply |
1 |
|
lung - chemistry - drug effects |
1 |
|
lung - cytology - drug effects - embryology |
1 |
|
lung - cytology - drug effects - physiology |
1 |
|
lung - drug effects - metabolism - physiology |
1 |
|
lung - growth & development - metabolism |
1 |
|
lung - immunology - metabolism |
1 |
|
lung - ultrastructure |
1 |
|
lung absorption |
1 |
|
lung barriers |
1 |
|
lung development |
1 |
|
lung diseases - enzymology - genetics |
1 |
|
lung diseases, obstructive - drug therapy - metabolism |
1 |
|
lung transplantation |
1 |
|
lung, human |
1 |
|
m2 muscarinic receptors |
1 |
|
maleimides - pharmacology |
1 |
|
management |
1 |
|
manganese superoxide dismutase |
1 |
|
membranes - metabolism |
1 |
|
methacholine chloride - pharmacology |
1 |
|
mice |
1 |
|
mice, transgenic |
1 |
|
mifepristone - pharmacology |
1 |
|
monocyte |
1 |
|
monocytes - metabolism |
1 |
|
mrna |
1 |
|
mrna expression |
1 |
|
mucus - secretion |
1 |
|
muscarinic agonists - metabolism |
1 |
|
muscarinic agonists - pharmacology |
1 |
|
muscarinic antagonists |
1 |
|
muscarinic antagonists - chemistry - metabolism - therapeutic use |
1 |
|
muscarinic antagonists - pharmacology |
1 |
|
muscarinic receptor subtype |
1 |
|
muscarinic receptor subtypes |
1 |
|
muscarinic receptors |
1 |
|
muscle contraction - drug effects |
1 |
|
muscle relaxation - drug effects |
1 |
|
muscle, smooth - cytology - enzymology |
1 |
|
muscle, smooth - drug effects |
1 |
|
muscle, smooth - drug effects - innervation - physiology |
1 |
|
muscle, smooth - drug effects - metabolism |
1 |
|
muscle, smooth - drug effects - metabolism - ultrastructure |
1 |
|
muscle, smooth - metabolism - pathology |
1 |
|
muscle, smooth, vascular - drug effects - physiology |
1 |
|
myocardial contraction |
1 |
|
myocardium - cytology - metabolism |
1 |
|
myocardium - metabolism |
1 |
|
n-methylscopolamine |
1 |
|
nanocrystals |
1 |
|
nasal mucosa - chemistry - metabolism |
1 |
|
nasal mucosa - drug effects - metabolism - pathology |
1 |
|
neonatal measurements |
1 |
|
neprilysin - analysis |
1 |
|
neurogenic inflammation |
1 |
|
neurokinin a - analogs & derivatives - pharmacology |
1 |
|
neurokinin b - analogs & derivatives - pharmacology |
1 |
|
neurokinin-2 receptor |
1 |
|
neuropeptides |
1 |
|
neutral endopeptidase |
1 |
|
nf-kappa b - metabolism |
1 |
|
nitric oxide - analysis |
1 |
|
nk1 and nk2 receptors |
1 |
|
nk1 receptors |
1 |
|
non-isotopic in situ hybridization |
1 |
|
norepinephrine |
1 |
|
northern blot |
1 |
|
northern blot analysis |
1 |
|
nuclear rna run‐on assay |
1 |
|
obstructive lung diseases |
1 |
|
odds ratio |
1 |
|
organ culture techniques |
1 |
|
osmolar concentration |
1 |
|
ovalbumin - administration & dosage |
1 |
|
ovalbumin - administration & dosage - immunology |
1 |
|
oxidant |
1 |
|
oxidants - antagonists & inhibitors - blood |
1 |
|
oxidants - metabolism |
1 |
|
ozone |
1 |
|
ozone - pharmacology |
1 |
|
paf (platelet activating factor) receptor |
1 |
|
paf receptor antagonist |
1 |
|
paraffin embedding |
1 |
|
parasympathetic nervous system - physiopathology |
1 |
|
parasympatholytics - diagnostic use |
1 |
|
parasympatholytics - metabolism |
1 |
|
parasympatholytics - pharmacology |
1 |
|
peptide fragments - pharmacology |
1 |
|
pertussis toxin |
1 |
|
pindolol - analogs & derivatives - metabolism - pharmacology |
1 |
|
piperidines - diagnostic use |
1 |
|
piperidines - metabolism |
1 |
|
piperidines - pharmacology |
1 |
|
pirenzepine |
1 |
|
pirenzepine - analogs & derivatives - pharmacology |
1 |
|
pirenzepine - diagnostic use |
1 |
|
pirenzepine - pharmacology |
1 |
|
plasmids |
1 |
|
platelet activating factor - biosynthesis - genetics |
1 |
|
platelet activating factor - pharmacology |
1 |
|
platelet membrane glycoproteins - agonists - genetics |
1 |
|
plethysmography, whole body |
1 |
|
pneumonia - physiopathology |
1 |
|
polymorphism, single nucleotide |
1 |
|
predictive value of tests |
1 |
|
pregnancy |
1 |
|
promoter regions, genetic |
1 |
|
propanolamines - metabolism - pharmacology |
1 |
|
prospective studies |
1 |
|
prostaglandin e2 |
1 |
|
prostaglandin-endoperoxide synthases - drug effects - metabolism |
1 |
|
protease |
1 |
|
protease inhibitors - pharmacology |
1 |
|
protective agents - pharmacology |
1 |
|
protein biosynthesis |
1 |
|
protein isoforms - metabolism |
1 |
|
protein kinase c |
1 |
|
protein kinase c - antagonists & inhibitors - metabolism |
1 |
|
protein kinase c - metabolism |
1 |
|
protein kinase c - physiology |
1 |
|
protein kinases - metabolism |
1 |
|
protein synthesis inhibitors - pharmacology |
1 |
|
protein-serine-threonine kinases - genetics - metabolism |
1 |
|
protein-serine-threonine kinases - metabolism |
1 |
|
proteins - genetics |
1 |
|
pulmonary alveoli - metabolism |
1 |
|
pulmonary arteries |
1 |
|
pulmonary artery |
1 |
|
pulmonary artery - anatomy & histology - drug effects - physiology |
1 |
|
pulmonary circulation - drug effects |
1 |
|
pulmonary delivery |
1 |
|
pulmonary disease, chronic obstructive - diagnosis - genetics |
1 |
|
pulmonary disease, chronic obstructive - etiology - metabolism |
1 |
|
pulmonary veins - anatomy & histology - drug effects - physiology |
1 |
|
pyrilamine - pharmacology |
1 |
|
quinuclidinyl benzilate - diagnostic use |
1 |
|
quinuclidinyl benzilate - metabolism |
1 |
|
rabbits |
1 |
|
radioimmunoassay |
1 |
|
radioligand binding |
1 |
|
rat |
1 |
|
rational particle design |
1 |
|
rats, inbred bn |
1 |
|
rats, inbred strains |
1 |
|
rats, sprague-dawley |
1 |
|
reactive oxygen species - metabolism |
1 |
|
receptor |
1 |
|
receptor autoradiography |
1 |
|
receptor, bradykinin b1 |
1 |
|
receptor, bradykinin b2 |
1 |
|
receptor, muscarinic m2 |
1 |
|
receptors, adrenergic - genetics |
1 |
|
receptors, adrenergic, beta - analysis |
1 |
|
receptors, adrenergic, beta - analysis - genetics |
1 |
|
receptors, adrenergic, beta - analysis - genetics - physiology |
1 |
|
receptors, adrenergic, beta - classification - genetics - metabolism |
1 |
|
receptors, adrenergic, beta - drug effects |
1 |
|
receptors, adrenergic, beta - drug effects - genetics - metabolism |
1 |
|
receptors, adrenergic, beta - drug effects - metabolism |
1 |
|
receptors, adrenergic, beta - drug effects - metabolism - physiology |
1 |
|
receptors, adrenergic, beta - genetics |
1 |
|
receptors, adrenergic, beta - genetics - metabolism |
1 |
|
receptors, adrenergic, beta - metabolism |
1 |
|
receptors, adrenergic, beta-1 - analysis - drug effects - genetics |
1 |
|
receptors, adrenergic, beta-1 - biosynthesis - drug effects |
1 |
|
receptors, adrenergic, beta-1 - drug effects - metabolism |
1 |
|
receptors, adrenergic, beta-1 - genetics - metabolism |
1 |
|
receptors, adrenergic, beta-2 - analysis - drug effects |
1 |
|
receptors, adrenergic, beta-2 - analysis - drug effects - genetics |
1 |
|
receptors, adrenergic, beta-2 - biosynthesis - drug effects |
1 |
|
receptors, adrenergic, beta-2 - biosynthesis - genetics |
1 |
|
receptors, adrenergic, beta-2 - biosynthesis - genetics - metabolism |
1 |
|
receptors, adrenergic, beta-2 - drug effects - metabolism |
1 |
|
receptors, adrenergic, beta-2 - genetics - metabolism |
1 |
|
receptors, adrenergic, beta-2 - metabolism |
1 |
|
receptors, adrenergic, beta-2 - physiology |
1 |
|
receptors, bradykinin |
1 |
|
receptors, bradykinin - biosynthesis |
1 |
|
receptors, calcitonin |
1 |
|
receptors, calcitonin - chemistry |
1 |
|
receptors, cell surface |
1 |
|
receptors, cell surface - analysis - genetics |
1 |
|
receptors, cell surface - metabolism |
1 |
|
receptors, cell surface - physiology |
1 |
|
receptors, cholinergic - metabolism - physiology |
1 |
|
receptors, g-protein-coupled |
1 |
|
receptors, gaba-a - analysis |
1 |
|
receptors, glucocorticoid - drug effects - metabolism |
1 |
|
receptors, histamine h1 - genetics - metabolism |
1 |
|
receptors, muscarinic - biosynthesis - metabolism |
1 |
|
receptors, muscarinic - drug effects - genetics - metabolism |
1 |
|
receptors, muscarinic - drug effects - metabolism |
1 |
|
receptors, muscarinic - drug effects - physiology |
1 |
|
receptors, muscarinic - genetics |
1 |
|
receptors, muscarinic - genetics - metabolism |
1 |
|
receptors, muscarinic - isolation & purification |
1 |
|
receptors, muscarinic - metabolism |
1 |
|
receptors, neurokinin-1 - analysis - antagonists & inhibitors - metabolism |
1 |
|
receptors, neurokinin-1 - antagonists & inhibitors - metabolism |
1 |
|
receptors, neurokinin-2 |
1 |
|
receptors, neurokinin-2 - antagonists & inhibitors - metabolism |
1 |
|
receptors, neurokinin-2 - drug effects - genetics |
1 |
|
receptors, neurokinin-2 - drug effects - metabolism |
1 |
|
receptors, neurokinin-2 - physiology |
1 |
|
receptors, neurotransmitter - drug effects - physiology |
1 |
|
receptors, neurotransmitter - metabolism |
1 |
|
receptors, tachykinin |
1 |
|
recombinant fusion proteins - biosynthesis - genetics |
1 |
|
rehabilitation |
1 |
|
reproducibility of results |
1 |
|
respiratory function tests |
1 |
|
respiratory hypersensitivity |
1 |
|
respiratory hypersensitivity - diagnosis |
1 |
|
respiratory mechanics |
1 |
|
respiratory mucosa - cytology - metabolism |
1 |
|
respiratory physiological phenomena |
1 |
|
respiratory sounds |
1 |
|
response elements - drug effects - physiology |
1 |
|
rna, antisense - metabolism |
1 |
|
rna, messenger - analysis - biosynthesis |
1 |
|
rna, messenger - analysis - metabolism |
1 |
|
rna, messenger - drug effects |
1 |
|
rna, messenger - genetics - metabolism |
1 |
|
salbutamol |
1 |
|
salivary glands - metabolism |
1 |
|
salmeterol |
1 |
|
scopolamine derivatives - chemistry - metabolism - therapeutic use |
1 |
|
scopolamine derivatives - metabolism |
1 |
|
scopolamine hydrobromide - metabolism |
1 |
|
signal transduction - genetics |
1 |
|
size effect |
1 |
|
skin - chemistry |
1 |
|
smoking - adverse effects - physiopathology |
1 |
|
smooth muscle, airway |
1 |
|
sodium fluoride - pharmacology |
1 |
|
stimulation, chemical |
1 |
|
substance p - administration & dosage - analogs & derivatives - pharmacology |
1 |
|
substance p - pharmacology |
1 |
|
sulfates - metabolism |
1 |
|
sulfur radioisotopes |
1 |
|
swine |
1 |
|
tachykinin nk2 receptor |
1 |
|
tachykinins - physiology |
1 |
|
tetradecanoylphorbol acetate - pharmacology |
1 |
|
tissue distribution |
1 |
|
trachea |
1 |
|
trachea - cytology - enzymology |
1 |
|
trachea - cytology - metabolism |
1 |
|
trachea - drug effects |
1 |
|
trachea - drug effects - innervation - physiology |
1 |
|
trachea - drug effects - metabolism |
1 |
|
trachea - drug effects - metabolism - ultrastructure |
1 |
|
trachea - drug effects - physiology |
1 |
|
trachea - drug effects - secretion |
1 |
|
trachea - innervation |
1 |
|
trachea - metabolism |
1 |
|
transcription |
1 |
|
transcription factor |
1 |
|
transcription factors - biosynthesis |
1 |
|
transcription, genetic - drug effects |
1 |
|
transcription, genetic - drug effects - genetics |
1 |
|
transcription, genetic - drug effects - physiology |
1 |
|
transforming growth factor beta - pharmacology |
1 |
|
transgenes - genetics |
1 |
|
triazoles - pharmacology |
1 |
|
tritium |
1 |
|
tritium - diagnostic use |
1 |
|
tuberculosis |
1 |
|
tuberculosis, pulmonary - blood - genetics |
1 |
|
tumor necrosis factor-alpha - pharmacology |
1 |
|
up-regulation - drug effects |
1 |
|
upregulation |
1 |
|
uteroglobin |
1 |
|
valine - chemistry |
1 |
|
vasodilation |
1 |
|
vasodilation - drug effects |
1 |
|
vasomotor system - metabolism |
1 |
|
vasospasm |
1 |
|
virulence factors, bordetella - pharmacology |
1 |
|
world health |
1 |
|
β- adrenergic receptors |
1 |
|
β-adrenoceptor |
1 |
|
β-adrenoceptor agonist |
1 |
|
β-adrenoceptors |
1 |
|
β2-adrenergic receptor |
1 |
|
β2-adrenergic receptors |
1 |
|
β2-adrenoceptor |
1 |
|
β2ar polymorphisms |
1 |
